Normal hematopoietic stem cells within the AML bone marrow have a distinct and higher ALDH activity level than co-existing leukemic stem cells.
Persistence of leukemic stem cells (LSC) after chemotherapy is thought to be responsible for relapse and prevents the curative treatment of acute myeloid leukemia (AML) patients. LSC and normal hematopoietic stem cells (HSC) share many characteristics and co-exist in the bone marrow of AML patients....
Guardado en:
Autores principales: | Gerrit J Schuurhuis, Michael H Meel, Floris Wouters, Lisa A Min, Monique Terwijn, Nick A de Jonge, Angele Kelder, Alexander N Snel, Sonja Zweegman, Gert J Ossenkoppele, Linda Smit |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/afdfbec2f3a140adb7a2c8c49ec3e1ce |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Mutant H3 histones drive human pre-leukemic hematopoietic stem cell expansion and promote leukemic aggressiveness
por: Meaghan Boileau, et al.
Publicado: (2019) -
Suppression of Transposable Elements in Leukemic Stem Cells
por: Anthony R. Colombo, et al.
Publicado: (2017) -
Identification of leukemic and pre-leukemic stem cells by clonal tracking from single-cell transcriptomics
por: Lars Velten, et al.
Publicado: (2021) -
Hematopoietic stem cell transplantation
por: Eleftheria Hatzimichael, et al.
Publicado: (2010) -
Risk Stratification, Measurable Residual Disease, and Outcomes of AML Patients with a Trisomy 8 Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
por: Donata Backhaus, et al.
Publicado: (2021)